Human pilot study links chitosan fiber to lower blood microplastics

By AI, Created 3:01 PM UTC, May 27, 2026, /AGP/ – Sifts says a new pilot-controlled human study points to a possible gut-based way to reduce circulating microplastics after exposure. The early findings in 21 healthy adults could steer more research toward gastrointestinal sequestration as a practical target.

Why it matters: - The study shifts attention from avoiding microplastics to understanding what may help the body handle particles after exposure. - If confirmed in larger studies, a gut-based approach could open a new path for reducing internal microplastic burden. - Microplastics are being detected in food, water, air and human biological samples, making post-exposure support a growing research question.

What happened: - Sifts published an analysis of a new pilot-controlled human study on PCC-chitosan, a naturally derived dietary fiber. - The study appeared in the Journal of Xenobiotics and followed 21 healthy adults for 15 days. - Eleven participants received 0.8 g/day of PCC-chitosan. - Ten matched controls received placebo. - Microplastics were detected in blood at baseline in every participant. - After 15 days, the PCC-chitosan group showed a reported 26.3% mean reduction in circulating microplastic concentration. - The placebo group showed no significant change.

The details: - Researchers proposed that chitosan may work through gastrointestinal sequestration. - The proposed mechanism is that the fiber forms networks in the digestive tract that can interact with microplastic particles and support normal elimination. - Sifts said the findings are early and should be interpreted carefully. - The study was small and short in duration. - Microplastic measurement remains technically complex. - Larger, independently replicated studies are needed. - The full analysis is available at Sifts.co. - Sifts published the article through The Filtered Blog, its consumer education platform focused on microplastic exposure, emerging research and environmental wellness.

Between the lines: - The research adds to a broader scientific shift toward studying the digestive tract as a practical target in microplastic science. - A 2025 human stool study found PCC-chitosan was associated with increased fecal excretion of several microplastic types after a standardized meal. - A separate 2025 animal study in Scientific Reports found chitosan increased fecal excretion and reduced intestinal retention of polyethylene microplastics in rats. - Sifts is framing the topic as a public-health and consumer-wellness issue rather than a purity or panic story. - “This study is important because it moves the conversation from exposure alone to post-exposure biology,” said Jacob Gilson, founder of Sifts. - “Microplastics are an emerging biomarker with growing implications for human health,” said Dr. Nehal Mehta, MD, MSCE, FACC, lead clinical advisor at Sifts.

What’s next: - The key next step is larger human research that can verify whether PCC-chitosan consistently lowers circulating microplastics. - Future studies will need stronger measurement methods and longer follow-up. - Sifts says the article is meant to help consumers understand the science without overstating what the data can prove today. - Study Note: The findings are preliminary and should not be interpreted as proof of guaranteed results for any product.

The bottom line: - The early human data make the gut a more serious target in microplastic research, but the evidence is still preliminary and far from settled.